EMBOSPHERE MICROSPHERES

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-03-21 for EMBOSPHERE MICROSPHERES manufactured by Biosphere Medical Sa.

Event Text Entries

[40745938]
Patient Sequence No: 1, Text Type: N, H10


[40745939] A (b)(6) underwent embolization of the prostate for treatment of benign prostatic hyperplasia. Embosphere microspheres were used as the embolic agent. Immediately after the procedure a full body rash developed. The patient had taken most of the other medications that had been administered previously, suggesting they weren't the etiology of the reaction. Rash became desquamating over the next few days and there are still multiple erythematous patches remaining several months after the procedure.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number5513247
MDR Report Key5513247
Date Received2016-03-21
Date of Report2016-03-17
Date of Event2016-01-26
Report Date2016-03-17
Date Reported to FDA2016-03-17
Date Reported to Mfgr2016-03-17
Date Added to Maude2016-03-21
Event Key0
Report Source CodeUser Facility report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEMBOSPHERE MICROSPHERES
Generic NameDEVICE, NEUROVASCULAR EMBOLIZATION
Product CodeNAJ
Date Received2016-03-21
Lot Number1575929
Device Expiration Date2018-03-30
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOSPHERE MEDICAL SA
Manufacturer AddressUS AGENT: JOHN KNORPP MERIT MEDICAL SYSTEMS, INC. 1600 MERIT PARKWAY SOUTH JORDAN UT 84095 US 84095


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-03-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.